Novoheart Opens New Research and Development Location

Novoheart (TSXV:NVH) announced it opened a new US location in California.
As quoted in the press release:

Novoheart’s established presence in California marks a critical milestone in the Company’s early steps towards engaging the expansive North American market and supports its mission of positioning itself as a key player in the transformation of drug discovery.
“We are very excited to further expand our presence in North America and believe that working in The Cove provides an ideal environment to advance both our product and business development,” said Ronald Li, CEO of Novoheart. “The type of collaborative research between ours and UCI’s team clearly demonstrates the significant value of being in a state-of-the-art facility with other leading specialists.

Click here to read the full press release.

Source: www.marketwired.com